Cowen Inc’s Heron Therapeutics HRTX Stock Holding History

Cowen Inc’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-18,000	Closed	-$481K	–	305
2015 Q4	$481K	Buy	+18,000	New	+$481K	0.04%	195

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cowen Inc's HRTX Position: Q1 2016 in Review

Cowen Inc sold out of Heron Therapeutics (HRTX) in Q1 2016, closing a stake of 18,000 shares — an estimated $481K sold.

Cowen Inc first reported a position in HRTX in Q4 2015 and held it in 1 quarter. The position peaked at $481K in Q4 2015. 99 funds tracked by Wall St. Rank hold HRTX as of Q1 2016.

Cowen Inc reported no remaining Heron Therapeutics position as of Q1 2016 after selling out during the quarter.
Cowen Inc sold 18,000 Heron Therapeutics shares in Q1 2016, an estimated $481K.
Cowen Inc first reported a position in Heron Therapeutics in Q4 2015 and held it in 1 quarter.
Cowen Inc's Heron Therapeutics position peaked at $481K in Q4 2015.
99 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2016.

Based on Cowen Inc's 13F filing for Q1 2016, filed 16 May 2016.